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Uncoupling protein 2UCP1 andUCP3 aremembers of the uncoupling protein (UCP) subfamily and are localized in the innermitochondrial
membrane.Whereas UCP1's central role in non-shivering thermogenesis is acknowledged, the function and even
tissue expression pattern of UCP3 are still under dispute. BecauseUCP3 properties regarding transport of protons
are qualitatively identical to those of UCP1, its expression in brown adipose tissue (BAT) alongside UCP1 requires
justiﬁcation. In this work, we tested whether any correlation exists between the expression of UCP1 and UCP3
in BAT by quantiﬁcation of protein amounts in mouse tissues at physiological conditions, in cold-acclimated
and UCP1 knockout mice. Quantiﬁcation using recombinant UCP3 revealed that the UCP3 amount in BAT (0.51
ng/(μg total tissue protein)) was nearly one order of magnitude higher than that in muscles and heart. Cold-
acclimated mice showed an approximate three-fold increase in UCP3 abundance in BAT in comparison to mice
in thermoneutral conditions. Surprisingly, we found a signiﬁcant decrease of UCP3 in BAT of UCP1 knockout
mice, whereas the protein amount in skeletal and heart muscles remained constant. UCP3 abundance decreased
even more in cold-acclimated UCP1 knockout mice. Protein quantiﬁcation in UCP3 knockout mice revealed no
compensatory increase in UCP1 or UCP2 expression. Our results do not support the participation of UCP3 in
thermogenesis in the absence of UCP1 in BAT, but clearly demonstrate the correlation in abundance between
both proteins. The latter is important for understanding UCP3's function in BAT.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
UCP1 and UCP3, proteins of the mitochondrial uncoupling protein
subfamily (UCP), are implicated in the pathophysiology of different
diseases such as obesity, diabetes mellitus, ischemia, cancer, etc. [1–3].
However, the underlying molecular mechanisms and even the protein
distribution among tissues have been controversially discussed for
nearly two decades.
UCP3, ﬁrst described in muscles [4], has 57% and 55% homology to
UCP1 in humans and mice, respectively. Both UCP1 and UCP3 were
shown to transport protons [5–7]. However, whereas the role of UCP1
in non-shivering thermogenesis is accepted, the function of UCP3 is





. This is an open access article undertransport fatty acids, lipid peroxides and pyruvate [11–14]. Results
from experiments using knockout or overexpression of UCP3 in murine
skeletal muscles imply the protective role of UCP3 against triglyceride
accumulation [15,16].
Although the expression of UCP3 at the protein level was reported
for muscle [17], heart [18], brown adipose tissue [19], white adipose
tissue [20], spleen and thymus [21], the investigation of its function
has mostly been focused on how it works in muscles. The generation
of UCP1 and UCP3 knockout mice reveals that such mice have no con-
spicuous phenotype under physiological conditions [22;23]. The cold
adaptation of a UCP1 knockout mouse conﬁrmed the function of UCP1
as a mediator of non-shivering thermogenesis [24,25]. Because both
UCP1 and UCP3 are localized in BAT, it is possible that the function of
one protein can be taken over by the other (sister) uncoupling protein.
One of the few existing comparative investigations of UCP1 and UCP3
describes themRNA interdependence of UCP1 in BATwithUCP3 in skel-
etal muscles [26]. However, in contrast to UCP1, UCP3 is characterized
by a rapid turnover [27] which makes protein expression analysis so
important in the investigation of UCP3 function and regulation. It was
reported that UCP3 abundance increases in skeletal muscle of cold-the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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that it takes over the UCP1 thermogenic function [28].
The understanding of UCP3's expression pattern under different
physiological and challenging (cold acclimation) conditions will pro-
vide an important indication for revealing its function. Therefore, the
goals of the present work were (i) to quantify the expression of UCP3
in mouse tissues using the UCP3 recombinant protein and a novel poly-
clonal antibody; (ii) to evaluate whether and in which tissues UCP1 and
UCP3 may substitute for each other by compensatory increases in pro-
tein abundance, using the model of UCP1 and UCP3 knockout mice
and (iii) to verify whether there is any interaction between UCP1 and
UCP3 at the protein level in general.
2. Materials and methods
2.1. Chemicals
All of the chemicals we used, except for those mentioned below,
were acquired by Roche (Austria), Sigma Aldrich (Austria), Biorad
(Austria), Amersham Biosciences, and GE Healthcare (Austria).
2.2. Recombinant proteins
Recombinant proteins, murine UCP1 (mUCP1), human UCP2
(hUCP2), mUCP2, mUCP3, mUCP4-eGFP and mUCP5, were used for an-
tibody validation and for quantiﬁcation as a standard in Western blot
analysis. Recombinant production of mUCP1, hUCP2, mUCP4-eGFP
and mUCP5 has been previously described [29,30]. Production and re-
constitution of mUCP2 andmUCP3were performed in a similar fashion.
In brief, the open reading frames of mUCP2 and mUCP3 were obtained
as full length cDNA clones IRAVp968G0921D and IRCKp5014J1815Q
(BioCat, Germany). Mouse ucp2 was inserted in the NdeI and EcoRI
sites, mouse ucp3 — in the NheI and a BamHI sites of pET24a +
(Novagen, Germany), respectively. For protein expression, pET24a +
containingmucp2 ormucp3were transfected into the E. coli expression
strain Rosetta (DE3) (Novagen, Germany). Bacteria were grown to OD
600 0.3–0.5 before protein expression was induced by addition of
1 mM isopropyl-β-D-thiogalactopyranoside (IPTG). After incubation
for an additional 2.5 h, bacteria were harvested by centrifugation. A
suspended bacteria pellet was lysed using a French press (Constant Sys-
tems Limited, UK). Inclusion bodies were collected by centrifugation at
14,000 g. Approximately 3 mg of mUCP2 or mUCP3 were solubilized
from inclusion bodies using 2% sarcosyl and 1 mM DTT. 100 mg E. coli
polar lipid (Avanti polar lipids, Alabaster, USA), 300 μg Triton X-114,
75 μg octyl-polyoxyethylene and 2 mM GTP were added to the solubi-
lized mUCP2 or mUCP3. Sarcosyl and GTP were removed by dialysis,
and the buffer was thereby changed to the assay buffer (50 mM NaSO4,
10 mM Tris, 10 mM MES and 0.6 mM EGTA, pH 7.34). The dialysate
was passed through a hydroxyapatite column (Bio-Rad, Germany) to re-
move decomposed proteins. Non-ionic detergentswere eliminated using
Bio Beads (Bio-Rad, Germany). Proteoliposomes containing mUCP2 or
mUCP3 were stored at−80 °C.
2.3. Animals
UCP1−/− [24], UCP2−/− [31], UCP3−/− [17] and theirwild type (wt)
controls used in this study were backcrossed for 10 generations on the
C57BL/6 background. Alternatively, three months old wt C57BL/6 mice
were used for the experiments on isolated mitochondria. The animals
were routinely kept in a 12 h:12 h light–dark cycle, were acclimated
to 21–23 °C (unless otherwise stated) and had unlimited access to
food (R70 Standard Diet, Lactamin) and tapwater. In some experiments
micewere acclimated to 4 °C or 30 °C for at least 4weeks.Micewere sin-
gle caged, cages were enriched with wooden chips, carton tube and
paper for mice welfare. All experiments were approved by the Animal
Ethics Committee of the North Stockholm region, Sweden.2.4. Tissue samples preparation
Animals were anaesthetised with a mixture of 79% CO2 and 21% O2
for 1 min and then decapitated. The extracted tissues were immediately
shock-frozen in liquid nitrogen for further investigation.We applied two
homogenisation protocols for different tissues [30,32]. To homogenize
brown (BAT) and inguinal white (WAT, [20]) adipose tissues, we used
a Potter homogenizer with a Teﬂon pestle. BAT and WAT were homog-
enized in RIPA buffer supplementedwith a protease inhibitor (Complete
mini). After centrifugation (14,000 g, 15 min, at 4 °C), the supernatant
was collected with a syringe, aliquoted and stored at−80 °C. Thymus,
spleen, brain and lungs were crushed using a mixer mill (MM200,
Retsch, Germany) in lysis buffer (50 mM Tris, 150 mM NaCl, 1% sodium
deoxycholate, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, pH 7.4) with a
protease inhibitors cocktail and then sonicated. Heart (He), skeletal
muscles (SkM) and stomach were ﬁrst trimmed into smaller pieces
with scissors and then treated as described above. After 30 min of incu-
bation on ice, the lysates were centrifuged 10min at 2,500 g. The super-
natants were collected, centrifuged again under same conditions,
aliquoted and stored at−80 °C. The total protein concentrationwas de-
termined with a Pierce BCA Protein Assay Kit (Thermo Scientiﬁc).
2.5. Mitochondrial protein isolation
BAT, WAT, He and SkM mitochondria were used for the UCP3 anti-
body validation and UCP3 quantiﬁcation. Extraction of BAT, WAT, He
and SkM (skeletal muscles: scapulae muscle, ScM and gastrocnemius
muscle, GMsc) and mitochondria isolation were performed according
to two different protocols [28] and [30] with amodiﬁcation as proposed
in [33].
2.6. Western blot analysis
Western blot (WB) analysis was performed as described previously
[34]. We modiﬁed the described protocol by using PVDF membranes
(Amersham Hybond-P PVDF Transfer Membrane GE Healthcare).
Probeswere incubated at 4 °C overnight (or at least for 8 h)with the pri-
mary antibody diluted in 2% BSA solution (bovine serum albumin,
SigmaAldrich, Austria) and for 1 h at RTwith the secondary antibody di-
luted in 2.5% milk solution. Detection was performed by luminescence
reaction using a secondary antibody against rabbit antibodies linked
with horseradish peroxidase (GE Healthcare, Austria) and ECL Western
blotting reagent (GE Healthcare, Austria) accomplished with a
ChemiDoc-It® 600 Imaging System (UVP, UK). The Launch Vision
Works LS software (UVP, UK) was used for quantiﬁcation. To ensure
an accurate comparison of UCP1 and UCP3 amounts in different tissues
or under different conditions, we methodically controlled the exposure
time to avoid signal saturation using the same software.
To control protein loading, themembraneswere strippedwith a low
pH strip solution (100 mM sodium citrate at pH 2.2) for at least 1 min,
washed, blocked for 30 min in block solution and incubated again
with antibodies against SDHA (succinate dehydrogenase complex sub-
unit A, Abcam ab14715; dilution 1:5,000), GAPDH (Glyceraldehyde-3-
phosphate dehydrogenase, Sigma-Aldrich, G8795; dilution 1:10,000)
and NDUFA9 (complex I, Invitrogen, 459100; dilution 1:3,000) diluted
in 2% BSA solution for at least 1 h at RT, and subsequently incubated
with horseradish peroxidase-linked anti-mouse IgG (GE Healthcare,
NA931).
2.7. Statistics
In each experiment 3–5 mice were used per group. All data are pre-
sented as mean values ± standard deviation (SD). Mean value for each
mouse was built from 2–3Western blots at the same conditions. Statis-
tical analyses for the comparison of two mice groups were performed
using Student's t test. By more than two mice groups one-way ANOVA
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p b 0.004 and p b 0.012 respectively. The analysis was carried out
using Sigma Plot 12.5 software.3. Results
3.1. UCP3 antibody generation and validation
The quality of antibodies is crucial for precise assessment of UCP tis-
sue distribution. Because the commercially available antibodies against
mUCP3 were not adequately speciﬁc enough for our research purposes,
we generated a new polyclonal antibody against the peptide sequence
located in the third matrix loop of the protein. We used tissue samples
fromUCP3 knockoutmice as a negative and recombinantUCP3 as a pos-
itive control to verify the speciﬁcity of the novel antibody in WB exper-
iments. Recombinant mUCP1, mUCP2, mUCP4-eGFP, mUCP5 and
mUCP3 [30,35] were used to exclude a cross-reactivity with other UCP
family members. Figure S1 (Supplementary Materials) demonstrates
that the anti-mUCP3 antibody we produced recognized recombinant
mUCP3 and UCP3 in skeletal muscle (SkM, Figure S1, A) of wt mice
and showed no cross-reactivity with other recombinant UCPs
(Figure S1, B).Fig. 1. UCP3 expression patterns in murine tissues under physiological conditions.
(A) UCP3 was detected in skeletal muscle (SkM), heart (He), brown adipose tissue
(BAT) and white adipose tissue (WAT) of wild type (wt) mice. Corresponding tissues
from UCP3−/−mice were used as a negative control. (B–C) Kidney (Ki), liver (Li), brain
(B), testes (Tes), thymus (Th), spleen (Sp), lung (Lu) and stomach (St) showno detectable
UCP3 expression. 25 μg of total protein from the tissuewere loaded per lane. Fivemice per
group were tested. (D) UCP3 expression in isolated mitochondria. 20 μg isolated
mitochondria from He, SkM and 10 μg isolated mitochondria from BAT were loaded per
lane. Recombinant mouse UCP3 (mUCP3, 5 ng) was used as a positive control. Antibodies
against GAPDH, SDHA and NDUFA9 were used as a control for protein loading and
mitochondria amount. Six mice were tested.3.2. UCP3 distribution in murine tissues at protein level
First, we compared the protein distribution in tissues ofwt andUCP3
knockout mice under physiological conditions to evaluate the contro-
versial reports about UCP3 tissue localization described in Introduction.
Fig. 1A demonstrates that UCP3 is expressed in brown adipose tissue
(BAT), inguinal white adipose tissue (WAT), skeletal muscle (SkM)
and heart (He) of wt mice, but not in the knockout controls. We did
not detect UCP3 in the liver (Li), kidney (Ki), brain (B), testis (Tes), thy-
mus (Th), spleen (Sp), lungs (Lu) and stomach (St) (Fig. 1B–C). This ex-
pression pattern generally conﬁrms the previous reports [23,36].
Interestingly, UCP3 expression seems to be different in rats compared
with mice; UCP3 was described in the murine thymus and spleen
(although in very low abundance), but no UCP3 was found in the rat
heart [21,37].
The data imply that UCP3 abundance in BAT is distinctly higher than
in SkM. To verify that this difference is not related to the mitochondria
amount, we repeated the experiment using isolated mitochondria
from heart, muscles and BAT. Fig. 1D shows that the UCP3 amount in
mitochondria isolated from BAT is indeed approximately two times
higher than in skeletal muscles.3.3. Quantiﬁcation of UCP3 expression at physiological conditions
To quantify the differences between the expression of UCP3 in BAT,
heart and muscles, we used the recombinant mouse protein (mUCP3).
Increasing concentrations of mUCP3 and the investigated tissues (20
and 50 μg of total protein) were gradually loaded onto a WB gel. We
plotted the values of WB density against known mUCP3 concentration
(Fig. 2A–D) and calculated the UCP3 content per 1 μg total cellular pro-
tein (Fig. 2E) to compare UCP3 abundance among different investigated
tissues. The UCP3 amount in BAT (0.51 ± 0.11) ng/(μg total protein)
was nearly one order of magnitude higher than that in gastrocnemius
muscle (0.058 ± 0.024) ng/(μg total protein), scapulae muscle
(0.038 ± 0.028) ng/(μg total protein), and heart (0.093 ± 0.02) ng/
(μg total protein). We performed the quantiﬁcation in isolated mito-
chondria in a similar manner (Fig. 2F). The results correspond with
those obtainedwith tissue. No differencewas observed between two di-
verse types of skeletal muscle tissue, which contradicts the previously
reported results [33].3.4. Quantiﬁcation of UCP3 expression in mice housed at
different temperatures
Next, we evaluated whether UCP3 expression is temperature-
sensitive akin to UCP1. For this, we measured UCP3 in BAT, ScM, GMsc
and He tissue probes taken frommice housed at 4 °C (cold acclimatiza-
tion), 21 °C (standard housing) and 30 °C (thermoneutral control). In-
deed, Fig. 3A shows that cold acclimatization of mice led to a three-
fold increase of UCP3 abundance in BAT (0.61 ng/(μg total protein) at
4 °C vs. 0.22 ng/(μg total protein) at 30 °C). To verify that the observed
UCP3 increase was not due to an increase in mitochondria number,
we performed UCP3 quantiﬁcation using isolated mitochondria. Fig.
3B conﬁrms that UCP3 abundance is temperature-sensitive and is up-
regulated at lower temperatures. Surprisingly, no change in UCP3 abun-
dance was measured in skeletal muscles and heart under similar tem-
perature conditions (Fig. 3C–E).
Fig. 2. Protein quantiﬁcation in tissues expressing UCP3. (A–D) Representative WBs for UCP3 quantiﬁcation in BAT (A), He (B), ScM (C) and GMsc (D) in wt mice under physiological
conditions. 20 μg and 50 μg of total protein from the investigated tissue (red circles) and different concentrations of recombinant UCP3 (mUCP3) were loaded for quantiﬁcation. (E–F)
Comparison of UCP3 amounts in different tissues (n = 4, E) and in isolated mitochondria (n = 7) of wt mice (F).
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ablated mice
To evaluate whether the lack of UCP1 can be substituted by the
up-regulation of UCP3 or vice versa at physiological conditions, we
determined the UCP3 expression in several tissues of the UCP1−/−
mice (Fig. 4) and UCP1 expression in UCP3−/−mice (Fig. 5). We de-
tected a signiﬁcantly lower UCP3 expression in BAT of UCP1−/− com-
pared to wt mice, whereas heart and both types of skeletal muscles
showed similar UCP3 abundance (Fig. 4A). To test whether the tem-
perature decrease would stimulate UCP3 expression, we compared
UCP1−/− mice at 4 °C and 21 °C (Fig. 4B). Surprisingly, UCP1−/−
mice acclimated at 4 °C showed the lowest UCP3 amount. Because
of high homology between UCP2 and UCP3 (~75%), we analysed
whether UCP2 is regulated in UCP1−/− mice. The results revealed
that UCP2 is not expressed in brown adipose tissue as a compensa-
tion for the lack of UCP1, and its abundance in tissues normallyexpressing UCP2 (spleen and thymus [35]) does not change
(Figure S2, A–B, Supplementary Materials).
To test whether the UCP1 expression level is also inﬂuenced by the
absence of UCP3, we measured it in UCP3−/−mice. UCP1 was neither
expressed in SkM nor He (Fig. 5A), and was not up-regulated in BAT
(Fig. 5B). Similarly, no compensatory expression of homologous UCP2
was detected in tissues where UCP3 (BAT, SkM or He, Figure S2, C) or
UCP2 (Sp and Th, Figure S2, D) are normally expressed.
3.6. Uncoupling proteins expression patterns in UCP2 — ablated mice
Finally, we analysed four UCP2−/−mice to test for the compensatory
up-regulation of UCP3 or UCP1. We did not ﬁnd expression of UCP1 or
UCP3 (data not shown) in tissues where UCP2 is normally expressed
[35]. BAT in UCP2−/− mice had a similar amount of UCP1 and UCP3
compared to thewt controls (Figure S3, A–B). No compensatory expres-
sion of UCP3 was detected in skeletal muscle or heart (Figure S3, B).
Fig. 3. Quantiﬁcation of UCP3 expression at different temperatures. (A) UCP3 amount in tissue lysates from brown adipose tissue, (C) heart, (D–E) skeletal muscles (ScM, D; GMsc, E) and
(B)mitochondria isolated fromBAT.Wild typemicewere housed at 30 °C, 21 °C and 4 °C. 20 μg of total protein from tissue or 10 μg isolatedmitochondriawere loaded per lane. The relative
UCP3 amount (r.u.) is a ratio between the band intensity of standard (mUCP3, 5 ng) and sample. Five mice were tested at 30 °C and 4 °C and four mice at 21 °C.
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Although one of theﬁrst reports aboutUCP3 described its expression
in muscles and BAT [36] more recent morphological and functional
studies generally refer to UCP3's predominance in skeletal muscles.
The lack of a commercially available, well characterized antibody is
still the main obstacle for a reliable comparison of UCP3 abundance in
different tissues. For this study we ﬁrst evaluated a self-designed anti-
body using positive (recombinant protein) and negative (knockout)
controls. The quantitative analysis of UCP3 abundance in skeletal mus-
cles, heart, and brown adipose tissue of mice revealed that BAT has
the highest UCP3 amount among the investigated tissues even at phys-
iological conditions. This difference was evenmore obvious in tissues of
cold-acclimated mice. We veriﬁed this ﬁnding by testing isolated mito-
chondria to exclude artefacts caused by different amounts of mitochon-
dria in various organs and the adaptive mitochondriogenesis described
for cold acclimation [38]. The different expression of rat UCP3 mRNA in
BAT in comparison to skeletal muscle after exposure to cold was report-
ed earlier [39]. The higher amounts of expressed protein in BAT and its
expression alongside UCP1may reﬂect a speciﬁc role of UCP3 in this tis-
sue compared to muscles and heart.Quantitative analysis using recombinant proteins further demon-
strated that the abundances of UCP3 and UCP1 in BAT are directly corre-
lated. The functional links between UCP1 and UCP3 were analysed in
mice at physiological conditions, in cold-acclimated, UCP1−/− and
UCP3−/−mice. Similar to UCP1, UCP3 in BAT was regulated by temper-
ature showing three times higher expression at 4 °C than at 30 °C
(thermoneutrality). At ﬁrst glance, these results would suggest a ther-
mogenic role of UCP3 in BAT as proposed earlier [39]. However, we
did not ﬁnd any compensatory expression of UCP3 in tissues of
UCP1−/− mice, in which the ablated UCP1 is normally present. We
evendetected a signiﬁcant decrease ofUCP3 in BAT of UCP1−/− animals,
in contrast to previously reported higher expression of UCP3 in skeletal
muscles of cold-acclimated UCP1 knockout mice [28]. This fact rather
indicates that UCP3 is not able to take over the thermogenic function
of UCP1 in BAT, again supporting the hypothesis about an organ-
speciﬁc function for UCP3. Moreover, UCP3 abundance in BAT is still ap-
proximately 400-fold lower, when compared to UCP1 amounts [35].
The various expression of UCP3 in BAT and muscles may be ex-
plained by the recently described differential gene regulation in both
tissues [40]. In BAT, the UCP3 transcription is stimulated by an addition-
al intronic enhancer with SP1/3 and PPARγ as core factors for ucp3 gene
Fig. 4. RepresentativeWestern blots and quantiﬁcation showing UCP3 expression in UCP1−/−mice. (A) UCP3 expression in brown adipose tissue, skeletal muscles (ScM, GMsc) and heart
of UCP1−/−mice compared to their wild type controls (wt). Data are presented as a mean values from threemice± SD. (B) UCP3 expression in BAT of UCP1−/−mice housed at different
temperatures. The relative amount (r.u.) of UCP3 is a ratio between the band intensity of standard (mUCP3, 5 ng) and sample. 25 μg of total protein from tissues were loaded per lane. The
number of tested mice was n = 5 at 4 °C and n = 4 at 21 °C.
Fig. 5. Representative Western blots and quantiﬁcation showing UCP1 expression in
UCP3−/−mice. (A) No compensatory expression of UCP1 in skeletal muscles, heart and
(B) BAT. Data are presented as a mean values from ﬁve mice ± SD. 20 μg of total protein
from tissues of UCP3−/− or wt mice were loaded per lane. The relative protein amounts
of UCP1 were calculated as a ratio between line intensity of standard (mUCP1, 250 ng)
and sample.
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or glutathionylation [42] – was proposed to inﬂuence the uncoupling
function of UCP3 and may differ in BAT and skeletal muscles.
We can only speculate about the molecular function of UCP3 and its
interconnection with UCP1, as is similar in other groups in this research
area to date. The direct correlation between UCP1 and UCP3 amounts in
BAT could most likely be explained by the speciﬁc UCP3 transport
function [43], coherent with the proton transport function of highly
abundant UCP1. This idea is supported by other groups that have previ-
ously reported on UCP3 exporting fatty acids from mitochondria pre-
dominantly during fatty acid oxidation [22]. Bouillaud et al. [44]
suggested a UCP3 function in pyruvate and glutamine metabolism as a
passive pyruvate transporter. This suggestion would ﬁt to the putative
involvement of UCP3 in the regulation of brown fat cell metabolism
similar to the function proposed for the highly homologous UCP2
(73%) in rapidly proliferating cells [34,35].
In conclusion, we show that (i) UCP3 is highly abundant in BAT and
the sensitivity of the protein expression to temperature is similar to that
of UCP1; and (ii) UCP3 expression is signiﬁcantly decreasedwhen UCP1
is knocked out. Further investigation of the molecular role of UCP3 in
BAT is an important task for the future, and may provide new insights
into its function.Conﬂict of interest
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